The story of Viagra, and its creator copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in revenue , its intellectual property lapse created a wave of lower-priced alternatives , significantly eroding its check here position . While some businesses may seek to capitalize on male sexual dysfu